Michael J.  Coyle net worth and biography

Michael Coyle Biography and Net Worth

EVP of Medtronic
Mike Coyle serves as Executive Vice President and President for the Cardiovascular Portfolio, a position he’s held since November 2020. In this role, Mike is responsible for optimizing Medtronic enterprise performance by supporting capital allocation, talent management, investments, and collaboration to create value across all of our Medtronic Operating Units (OUs), including the eight OUs that are organized under the Cardiovascular Portfolio.

Mike joined Medtronic in 2009 as Executive Vice President and Group President of the Cardiac and Vascular Group, where he oversaw and provided strategic direction for four Medtronic business divisions.

Prior to joining Medtronic, Mike provided leadership consulting services to private equity, venture capital, and medical device technology firms. From 2001 to 2007, he served as a divisional president at St. Jude Medical, where he led the company’s global pacemaker, implantable cardioverter defibrillator, and cardiac resynchronization businesses. He also led the company’s Daig Catheter division in an earlier president role. Additionally, Mike held numerous leadership positions at Eli Lilly & Company.

He earned a bachelor’s degree from Case Western Reserve University and a master’s degree in business administration from the Wharton School of Business, University of Pennsylvania. He currently serves on the board of directors for Haemonetics Corporation. He is also an advisor on the Case Western Reserve University School of Engineering BME Think Tank.

Mike is proud to serve as the executive sponsor of the Medtronic Women’s Network and past executive sponsor of the Asian Impact at Medtronic employee resource network. He champions a diverse, inclusive culture in Cardiovascular as a vital driver of innovation.

An avid traveler, Mike enjoys sharing trips with his wife, Laura, and his two children, Maya and Quinn.

What is Michael J. Coyle's net worth?

The estimated net worth of Michael J. Coyle is at least $16.44 million as of November 14th, 2019. Mr. Coyle owns 189,162 shares of Medtronic stock worth more than $16,441,961 as of March 28th. This net worth estimate does not reflect any other investments that Mr. Coyle may own. Learn More about Michael J. Coyle's net worth.

How do I contact Michael J. Coyle?

The corporate mailing address for Mr. Coyle and other Medtronic executives is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. Medtronic can also be reached via phone at (531) 438-1700 and via email at [email protected]. Learn More on Michael J. Coyle's contact information.

Has Michael J. Coyle been buying or selling shares of Medtronic?

Michael J. Coyle has not been actively trading shares of Medtronic in the last ninety days. Most recently, Michael J. Coyle sold 2,102 shares of the business's stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $109.77, for a transaction totalling $230,736.54. Following the completion of the sale, the executive vice president now directly owns 189,162 shares of the company's stock, valued at $20,764,312.74. Learn More on Michael J. Coyle's trading history.

Who are Medtronic's active insiders?

Medtronic's insider roster includes Richard Anderson (Director), Michael Coyle (EVP), Gary Ellis (EVP), Hooman Hakami (EVP), Bryan Hanson (EVP), Omar Ishrak (Chairman), Richard Kuntz (SVP), Bradley Lerman (SVP), John Liddicoat (EVP), Michael Marinaro (EVP), Geoffrey Martha (CEO), Karen Parkhill (CFO), Sean Salmon (EVP), Gregory Smith (EVP), Carol Surface (SVP), Rob Ten Hoedt (EVP), Brett Wall (EVP), Brett Wall (EVP), and Robert White (EVP). Learn More on Medtronic's active insiders.

Are insiders buying or selling shares of Medtronic?

During the last year, insiders at the medical technology company sold shares 7 times. They sold a total of 55,558 shares worth more than $4,712,507.68. The most recent insider tranaction occured on February, 21st when EVP Sean Salmon sold 30,695 shares worth more than $2,613,065.35. Insiders at Medtronic own 0.3% of the company. Learn More about insider trades at Medtronic.

Information on this page was last updated on 2/21/2024.

Michael J. Coyle Insider Trading History at Medtronic

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/14/2019Sell2,102$109.77$230,736.54189,162View SEC Filing Icon  
8/22/2018Sell145,544$95.50$13,899,452.00190,680View SEC Filing Icon  
See Full Table

Michael J. Coyle Buying and Selling Activity at Medtronic

This chart shows Michael J Coyle's buying and selling at Medtronic by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Medtronic Company Overview

Medtronic logo
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $86.92
Low: $84.10
High: $87.03

50 Day Range

MA: $85.21
Low: $83.08
High: $88.09

2 Week Range

Now: $86.92
Low: $68.84
High: $92.02

Volume

8,208,297 shs

Average Volume

6,191,965 shs

Market Capitalization

$115.41 billion

P/E Ratio

27.68

Dividend Yield

3.30%

Beta

0.76